G
L. M. Bannwart et al.
Paper
Synthesis
1H NMR (500 MHz, CD2Cl2): = 7.32–7.27 (m, 4 H), 7.20–7.15 (m,
1 H), 3.00–2.94 (m, 2 H), 2.34 (t, J = 7.0 Hz, 2 H), 1.67–1.60 (m, 2 H),
1.00–0.93 (m, 2 H), 0.73–0.67 (m, 2 H), 0.06 (s, 6 H).
DEPT-135 (126 MHz, CD2Cl2): = 130.2, 130.1, 30.4, 21.30, 21.25,
21.1, 15.9, 15.3, –3.5.
HRMS (ESI, MeOH): m/z [M + Na]+ calcd for C15H23NNaSSi: 300.1213;
found: 300.1209.
13C NMR (126 MHz, CD2Cl2): = 137.7, 129.4, 129.3, 126.2, 120.3,
29.7, 21.3, 21.1, 15.7, 15.2, –3.5.
4-({2-[(2,6-Dimethylphenyl)thio]ethyl}dimethylsilyl)butane-
nitrile (10)
DEPT-135 (126 MHz, CD2Cl2): = 129.4, 129.3, 126.2, 29.7, 21.3, 21.1,
15.7, 15.2, –3.5.
HRMS (ESI, MeOH): m/z [M + Na]+ calcd for C14H21NNaSSi: 286.1056;
found: 286.1060.
Protocol 1: Compound 10 (701 mg, 2.40 mmol, 69%) was isolated as a
light yellow liquid after purification by column chromatography
(340 g SiO2, Cy/EtOAc, 98:2 → 88:12).
Rf = 0.23 (Cy/EtOAc, 10:1).
4-{Dimethyl[2-(o-tolylthio)ethyl]silyl}butanenitrile (7)
Protocol 1: Compound 7 (891 mg, 3.21 mmol, 82%) was isolated as a
light yellow liquid after purification by column chromatography
(340 g SiO2, Cy/EtOAc 99:1, → 92:8).
1H NMR (500 MHz, CD2Cl2): = 7.10 (s, 3 H), 2.71–2.65 (m, 2 H), 2.53
(s, 6 H), 2.32 (t, J = 7.0 Hz, 2 H), 1.64–1.55 (m, 2 H), 0.89–0.83 (m, 2 H),
0.68–0.61 (m, 2 H), 0.00 (s, 6 H).
Protocol 2: (Ph3P)2PdCl2 (2.5 mol%) and Xantphos (5.0 mol%) were
added 4 times over a reaction time of 48 h. Compound 7 (525 mg,
1.89 mmol, 65%) was isolated as a light yellow liquid after purification
by column chromatography (100 g SiO2, Cy/EtOAc, 99:1 → 90:10).
13C NMR (126 MHz, CD2Cl2): = 143.6, 134.3, 128.6, 128.5, 120.3,
31.2, 22.4, 21.3, 21.1, 16.5, 15.2, –3.5.
DEPT-135 (126 MHz, CD2Cl2): = 128.6, 128.5, 31.2, 22.4, 21.3, 21.1,
16.5, 15.2, –3.5.
Rf = 0.18 (Cy/EtOAc, 20:1).
HRMS (ESI, MeOH): m/z [M + Na]+ calcd for C16H25NNaSSi: 314.1369;
found: 314.1369.
1H NMR (500 MHz, CD2Cl2): = 7.26–7.22 (m, 1 H), 7.16 (m, 2 H),
7.10–7.05 (m, 1 H), 3.03–2.87 (m, 2 H), 2.40–2.30 (m, 5 H), 1.70–1.59
(m, 2 H), 1.03–0.94 (m, 2 H), 0.76–0.66 (m, 2 H), 0.07 (s, 6 H).
4-({2-[(4-Bromophenyl)thio]ethyl}dimethylsilyl)butanenitrile
(11)
13C NMR (126 MHz, CD2Cl2): = 137.7, 137.0, 130.5, 128.0, 126.9,
125.9, 120.3, 28.9, 21.3, 21.1, 20.6, 15.5, 15.3, –3.4.
Protocol 1: 500 mg scale. Compound 11 (610 mg, 1.78 mmol, 71%)
was isolated as a light yellow liquid after purification by column chro-
matography (100 g SiO2, Cy/EtOAc, 98:2 → 81:19).
DEPT-135 (126 MHz, CD2Cl2): = 130.5, 127.9, 126.9, 125.9, 28.9,
21.3, 21.1, 20.6, 15.5, 15.3, –3.4.
HRMS (ESI, MeOH): m/z [M + Na]+ calcd for C15H23NNaSSi: 300.1213;
found: 300.1209.
Protocol 1: 3.00 g scale. Compound 11 (4.39 g, 12.8 mmol, 85%) was
isolated as a light yellow liquid after purification by column chroma-
tography (680 g SiO2, Cy/EtOAc, 98:2 → 82:18).
Rf = 0.29 (Cy/EtOAc, 10:1).
4-{Dimethyl{2-(m-tolylthio)ethyl]silyl}butanenitrile (8)
Protocol 1: Compound 8 (938 mg, 3.38 mmol, 84%) was isolated as a
light yellow liquid after purification by column chromatography
(340 g SiO2, Cy/EtOAc, 100:0 → 92:8).
1H NMR (500 MHz, CD2Cl2): = 7.45–7.37 (m, 2 H), 7.20–7.16 (m,
2 H), 3.00–2.90 (m, 2 H), 2.35 (t, J = 6.9 Hz, 2 H), 1.68–1.59 (m, 2 H),
0.98–0.90 (m, 2 H), 0.73–0.66 (m, 2 H), 0.06 (s, 6 H).
Rf = 0.17 (Cy/EtOAc, 20:1).
13C NMR (126 MHz, CD2Cl2): = 137.1, 132.4, 130.9, 120.3, 119.8,
29.9, 21.3, 21.1, 15.7, 15.2, –3.5.
1H NMR (500 MHz, CD2Cl2): = 7.18 (t, J = 7.6 Hz, 1 H), 7.13 (m, 1 H),
7.10 (m, 1 H), 6.99 (m, 1 H), 3.00–2.94 (m, 2 H), 2.37–2.31 (m, 5 H),
1.70–1.59 (m, 2 H), 0.99–0.92 (m, 2 H), 0.74–0.66 (m, 2 H), 0.07 (s,
6 H).
DEPT-135 (126 MHz, CD2Cl2): = 132.4, 130.9, 29.9, 21.3, 21.1, 15.7,
15.2, –3.5.
HRMS (ESI, MeOH): m/z [M
364.0161; found: 364.0158.
+
Na]+ calcd for C14H20BrNNaSSi:
13C NMR (126 MHz, CD2Cl2): = 139.3, 137.4, 129.9, 129.2, 127.1,
126.2, 120.3, 29.6, 21.6, 21.3, 21.1, 15.8, 15.3, –3.4.
4-({2-[(4-(tert-Butyl)phenyl]thio}ethyl)dimethylsilyl)butane-
DEPT-135 (126 MHz, CD2Cl2): = 129.9, 129.2, 127.1, 126.2, 29.6,
nitrile (12)
21.6, 21.3, 21.1, 15.8, 15.3, –3.4.
HRMS (ESI, MeOH): m/z [M + Na]+ calcd for C15H23NNaSSi: 300.1213;
found: 300.1209.
Protocol 1: Compound 12 (723 mg, 2.26 mmol, 78%) was isolated as a
colorless liquid after purification by column chromatography (50 g
SiO2, Cy/EtOAc, 98:2 → 82:18).
Rf = 0.29 (Cy/EtOAc, 10:1).
4-{Dimethyl[2-(p-tolylthio)ethyl]silyl}butanenitrile (9)
Protocol 1: Compound 9 (947 mg, 3.41 mmol, 84%) was isolated as a
light yellow liquid after purification by column chromatography
(340 g SiO2, Cy/EtOAc, 99:1 → 90:10).
1H NMR (500 MHz, CD2Cl2): = 7.36–7.29 (m, 2 H), 7.28–7.21 (m,
2H), 2.97–2.92 (m, 2 H), 2.34 (t, J = 7.0 Hz, 2 H), 1.67–1.60 (m, 2 H),
1.30 (s, 9 H), 0.98–0.93 (m, 2 H), 0.72–0.67 (m, 2 H), 0.06 (s, 6 H).
Rf = 0.18 (Cy/EtOAc, 20:1).
13C NMR (126 MHz, CD2Cl2): = 149.7, 134.0, 129.5, 126.5, 120.3,
34.9, 31.6, 30.1, 21.3, 21.1, 15.9, 15.3, –3.4.
1H NMR (500 MHz, CD2Cl2): = 7.24–7.19 (m, 2 H), 7.14–7.09 (m,
2 H), 2.97–2.88 (m, 2 H), 2.38–2.29 (m, 5 H), 1.68–1.58 (m, 2 H), 0.98–
0.89 (m, 2 H), 0.73–0.64 (m, 2 H), 0.05 (s, 6 H).
DEPT-135 (126 MHz, CD2Cl2): = 129.5, 126.5, 31.6, 30.1, 21.3, 21.1,
15.9, 15.3, –3.4.
13C NMR (126 MHz, CD2Cl2): = 136.5, 133.8, 130.2, 130.1, 120.3,
HRMS (ESI, MeOH): m/z [M + Na]+ calcd for C18H29NNaSSi: 342.1682;
30.4, 21.30, 21.25, 21.1, 15.9, 15.3, –3.5.
found: 342.1680.
© 2019. Thieme. All rights reserved. — Synthesis 2019, 51, A–L